Global Computer Aided Detection System Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Computer Aided Detection System Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Computer aided detection (CAD) System is a technology designed to decrease observational oversightsand thus the false negative ratesof physicians interpreting medical images. Prospective clinical studies have demonstrated an increase in breast cancer detection with CAD assistance.

Market Overview:

The latest research study on the global Computer Aided Detection System market finds that the global Computer Aided Detection System market reached a value of USD 409.42 million in 2022. It’s expected that the market will achieve USD 654.4 million by 2028, exhibiting a CAGR of 8.13% during the forecast period.

Increased competition

The competition among vendors will increase during the forecast period. Vendors will compete to deliver competitive advantages in the market on the basis of pricing, user-friendly interfaces, value-added benefits, and service portfolios. During the forecast period, we expect this competition to intensify with an increase in product extensions.

Artificial intelligence has great benefits for cancer screening, especially in the environment where resources are scarce

In recent years, the image recognition technology based on artificial intelligence has made great progress. Many researchers and companies are now studying different types of projects to improve the speed, accuracy and cost of cancer screening. CAD is an interdisciplinary technology combining elements of artificial intelligence and computer vision with radiological and pathology image processing. A typical application is the detection of a tumor. For instance, some hospitals use CAD to support preventive medical check-ups in mammography (diagnosis of breast cancer), the detection of polyps in the colon, and lung cancer. Artificial intelligence has great benefits for cancer screening, especially in the environment where resources are scarce. Artificial intelligence algorithms can be learned from a larger library than radiologists. In some cases, one million or more images. Once trained, artificial intelligence can be copied, except for the hardware to run it, but there is actually no extra cost, and copying a trained radiologist takes about 8 years of medical school and resident. Therefore, it can solve the problem of local lack of trained radiologists.

Region Overview:

Geographically, North America held the largest market share -- 38.72% in 2021.

Company Overview:

Hologic is one of the major players operating in the Computer Aided Detection System market, holding a share of 22.53% in 2022.

Hologic

Hologic, Inc. is a medical technology company primarily focused on womens health; it sells medical devices for diagnostics, surgery, and medical imaging.

ICAD (VuCOMP)

iCAD is a leading global provider of advanced image analysis, workflow solutions and radiation therapies for the early detection and treatment of cancer. iCAD offers advanced breast cancer detection solutions built on artificial intelligence, that enable radiologists to find cancers earlier while improving reading workflow.

Segmentation Overview:

As for product types, the X-Ray Imaging segment held the largest market share in 2021.

X-Ray Imaging

X-rays are a type of radiation called electromagnetic waves. X-ray imaging creates pictures of the inside of human body.

Computed Tomography

Computed tomography (CT) is a diagnostic imaging test used to create detailed images of internal organs, bones, soft tissue and blood vessels.

Ultrasound Imaging

Ultrasound imaging (sonography) uses high-frequency sound waves to view inside the body. Because ultrasound images are captured in real-time, they can also show movement of the body's internal organs as well as blood flowing through the blood vessels.

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a type of scan that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body.

Nuclear Medicine Imaging

Nuclear medicine imaging is a method of producing images by detecting radiation from different parts of the body after a radioactive tracer is given to the patient.

Application Overview:

The market's largest segment by application is the segment Breast Cancer, with a market share of 41.22% in 2021.

Breast Cancer

CAD is used in screening mammography (X-ray examination of the female breast).

Lung Cancer

Computer Aided Diagnosis System (CAD) is for early detection of lung cancer nodules from the Computer Tomography (CT) images.

Colon/ Rectal Cancer

CAD is available for detection of colorectal polyps in the colon in CT colonography.

Prostate Cancer

Computer Aided-Diagnose (CAD) could assist radiologists to decrease reading times and cost, and increase diagnostic effectiveness. CAD mimics radiologist and imaging guidelines to detect prostate cancer.

Liver Cancer

Liver cancer is one of the common diseases that cause the death. Early detection is important to diagnose and reduce the incidence of death. Improvements in medical imaging and image processing techniques have significantly enhanced interpretation of medical images. Computer-Aided Diagnosis (CAD) systems based on these techniques play a vital role in the early.

Bone cancer

Bone metastasis occurs when cancer cells from primary tumors relocate to bones. Computer aided detection system can help diagnosis.

Key Companies in the global Computer Aided Detection System market covered in Chapter 3:

ICAD (VuCOMP)
IBM
Siemens Healthineers
EDDA Technology
Riverain Technologies
MeVis Medical Solutions
Median Technologies
Hologic
Neusoft Corporation
Philips Healthcare

In Chapter 4 and Chapter 14.2, on the basis of types, the Computer Aided Detection System market from 2018 to 2029 is primarily split into:

X-Ray Imaging
Computed Tomography
Ultrasound Imaging
Magnetic Resonance Imaging
Nuclear Medicine Imaging
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Computer Aided Detection System market from 2018 to 2029 covers:

Breast Cancer
Lung Cancer
Colon/ Rectal Cancer
Prostate Cancer
Liver Cancer
Bone Cancer
Neurological/ Musculoskeletal/ Cardiovascular

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)